Healthcare • Diagnostics & Research
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SHC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
27 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 56 days ago
Red flags: 0
318 filers reported a long position in SHC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Sessa Capital IM, L.P. | $480.1M | 27.1M | +17.4% |
| Darsana Capital Partners LP | $479.3M | 27M | +3.8% |
| BlackRock, Inc. | $428.6M | 24.1M | +15.8% |
| Sculptor Capital LP | $426M | 24M | — |
| Sachem Head Capital Management LP | $276.2M | 15.6M | +33.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $216M | 12.2M | +13.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $212M | 11.9M | +12.6% |
| T. Rowe Price Investment Management, Inc. | $186.7M | 10.5M | +15.3% |
| AQR CAPITAL MANAGEMENT LLC | $186.4M | 10.7M | +59.7% |
| Jupiter Topco LLC | $149.1M | 8.4M | — |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.